Clinical Trial Update: Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating pemetrexed disodium with or without erlotinib hydrochloride in stage IIIB-IV or recurrent non-small cell lung cancer has completed, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Erlotinib hydrochloride (Erlotinib)
• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Bronchioloalveolar Carcinoma, Large Cell Lung Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-09-16